COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Related Care Services
In order to provide the best care for your child, providers in Neurology closely collaborate with departments and specialties across Children's National.
Our cardiac neurodevelopmental program, the only one of its kind in the region, monitors cognitive development in babies born with congenital heart disease.
The Concussion Program at Children’s National Hospital evaluates, monitors and manages the care of children and adolescents with concussions (known as mild traumatic brain injury).
The Cleft and Craniofacial Program at Children’s National brings together experts from 10 pediatric disciplines to provide complete care for children with craniofacial disorders. Our multidisciplinary pediatric team helps more than 400 children every year.
The Prenatal Pediatrics Institute at Children’s National Hospital in Washington, D.C., provides specialized care for babies during pregnancy, delivery and after birth.
The Leukodystrophy and Myelin Disorders Program at Children's National Hospital provides comprehensive services for children with inherited white matter diseases.
Our pediatric specialists treat children with a variety of different strokes each year. It is important for parents and caregivers to recognize the signs of a stroke and take immediate action.
The Neonatal Neurology and Neurocritical Care Program at Children’s National is the only one of its kind in the mid-Atlantic region and a leader in advancing neurologic care to some of our most critically ill newborns.
Our dedicated neurodevelopmental pediatricians and division staff evaluate and coordinate care for patients with developmental needs, from birth through age 21.
The Neurocritical Care Unit at Children’s National is the only pediatric neuro ICU in the Washington, D.C., area.
The Neuromuscular Medicine Program leverages the expertise of a multidisciplinary teams, cutting-edge research and innovative technologies to care for a spectrum of neuromuscular conditions affecting children from infancy to age 21.